Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
Go back to Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform| Gilead Sciences (NASDAQ: GILD) | Delayed: 143.44 +4.52 (3.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.92 | 52 Week High | $108.63 | |||
| Open | $140.00 | 52 Week Low | $71.39 | |||
| Day High | $143.89 | P/E | 79.25 | |||
| Day Low | $139.54 | EPS | $1.81 | |||
| Volume | 5,757,083 | |||||
